Rajbala Pharmaceutical And Surgicals Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 10-12-2024
- Paid Up Capital ₹ 0.10 M
as on 10-12-2024
- Company Age 4 Year, 8 Months
- Last Filing with ROC 31 Mar 2021
- Open Charges ₹ 3.00 M
as on 10-12-2024
About Rajbala Pharmaceutical And Surgicals
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2021. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹3.00 M.
Rajeev Kumar and Garima Jaswal serve as directors at the Company.
- CIN/LLPIN
U24230DL2020PTC363377
- Company No.
363377
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
22 Apr 2020
- Date of AGM
30 Nov 2021
- Date of Balance Sheet
31 Mar 2021
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Delhi, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Rajbala Pharmaceutical And Surgicals?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Rajeev Kumar  | Director | 22-Apr-2020 | Current |
| Garima Jaswal | Director | 22-Apr-2020 | Current |
Financial Performance of Rajbala Pharmaceutical And Surgicals.
Rajbala Pharmaceutical And Surgicals Private Limited, for the financial year ended 2021, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Rajbala Pharmaceutical And Surgicals?
In 2021, Rajbala Pharmaceutical And Surgicals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Grh Enterprises Private LimitedActive 5 years 9 monthsRajeev Kumar and Garima Jaswal are mutual person
Ayrus Sri Health Care Solutions Private LimitedActive 3 years 5 monthsRajeev Kumar is a mutual person
- Rajvans Pharmaceutical And Surgicals Private LimitedActive 3 years 11 months
Rajeev Kumar and Garima Jaswal are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
State Bank Of India Creation Date: 05 Jul 2022 | ₹3.00 M | Open |
How Many Employees Work at Rajbala Pharmaceutical And Surgicals?
Unlock and access historical data on people associated with Rajbala Pharmaceutical And Surgicals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Rajbala Pharmaceutical And Surgicals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Rajbala Pharmaceutical And Surgicals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
